Medicus Pharma: Prostate Cancer Breakthrough Tevevelix FDA Study Greenlit

By Proactive Investors / February 13, 2026 / www.youtube.com / Article Link

Medicus Pharma Ltd has received FDA clearance to launch a Phase 2b study of Teverelix(R) in advanced prostate cancer.

Recent News

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

Gold stocks down on metal price pullback

September 28, 2026 / www.canadianminingreport.com

Mining sector far outpaces tech over past three years

September 21, 2026 / www.canadianminingreport.com

Gold stocks down with GDXJ outperforming on rebalancing

September 21, 2026 / www.canadianminingreport.com

Copper slides as US apparently wavering on tariff hikes

September 14, 2026 / www.canadianminingreport.com

See all >